Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
HOLLISTON, Mass., May 05, 2025 ( GLOBE NEWSWIRE ) -- Harvard Bioscience, Inc. ( Nasdaq: HBIO ) will announce its financial results for the quarter ended March 31, 2025, before the market opens on May 12, 2025, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today - RTX ( NYSE:RTX )
RTX RTX has outperformed the market over the past 5 years by 2.97% on an annualized basis producing an average annual return of 16.99%. Currently, RTX has a market capitalization of $171.67 billion.
Leading Independent Proxy Advisory Firm ISS Recommends Harley-Davidson Shareholders Vote "FOR ALL" of Harley-Davidson's Highly Qualified Director Nominees - Harley-Davidson ( NYSE:HOG )
ISS Concludes That H Partners "Has Not Presented a Compelling Case for Change;" Notes that its "Campaign Has Almost Certainly Set the CEO Search Process Back" Highlights Progress Made Under CEO Jochen Zeitz and the Hardwire Strategic Plan
EU set to make it easier for UK professionals to work in the bloc
Brussels due to propose legislation to enable the recognition of qualifications of British lawyers and others ...
Lattice Semiconductor Shares Slide After Q1 Results: Details - Lattice Semiconductor ( NASDAQ:LSCC )
Lattice Semiconductor reports quarterly earnings of 22 cents per share, in line with the analyst consensus estimate. Quarterly revenue comes in at $120.15 million, which beat the analyst consensus estimate of $120.13 million.
Trump's crypto dealings face scrutiny as House Republicans unveil digital asset bill
US President Donald Trump's crypto businesses are drawing increased scrutiny on Capitol Hill and beginning to influence the progress of US digital asset legislation. As Republican lawmakers in the US House of Representatives unveiled their draft of a digital asset market structure bill on May 5, ...
Why Did PTC Therapeutics Stock Fall On Monday Despite Mid-Stage Study For Huntington's Hits Primary Goal? - PTC Therapeutics ( NASDAQ:PTCT )
39% reduction in HTT protein seen at 10mg dose in Stage 2 Huntington's patients. Plasma NfL dropped by 14% at 10mg dose after 24 months ( nominal p=0.03 ) . Don't miss this list of 10 overlooked stocks-including one paying a 9% dividend-before Wall Street catches on. PTC Therapeutics, Inc.
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
The order comes ahead of Trump's planned tariffs on pharmaceuticals imported into the U.S.
Why Helen of Troy Stock Plunged Today
Shares of home goods and wellness products company Helen of Troy ( NASDAQ: HELE ) plunged 10.4% on Monday. The company, which has encountered severe headwinds in recent months -- including an earnings report that underwhelmed and uncertainty over tariffs -- abruptly announced after market close ...





